CS
MLAB icon

Candriam SCA’s Mesa Laboratories MLAB Stock Holding History

Candriam SCA’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,150
Closed -$856K – 909
2022
Q4 		$856K Sell
5,150
-726
-12% -$114K 0.01% 729
2022
Q3 		$828K Sell
5,876
-2,221
-27% -$405K 0.01% 754
2022
Q2 		$1.65M Hold
8,097
– – 0.01% 543
2022
Q1 		$2.06M Buy
8,097
+1,500
+23% +$407K 0.01% 530
2021
Q4 		$2.16M Hold
6,597
– – 0.01% 525
2021
Q3 		$2M Hold
6,597
– – 0.01% 576
2021
Q2 		$1.79M Buy
6,597
+26
+0.4% +$6.59K 0.01% 599
2021
Q1 		$1.81M Hold
6,571
– – 0.02% 534
2020
Q4 		$1.88M Sell
6,571
-1,629
-20% -$448K 0.01% 546
2020
Q3 		$2.45M Hold
8,200
– – 0.02% 468
2020
Q2 		$1.78M Hold
8,200
– – 0.02% 506
2020
Q1 		$2M Hold
8,200
– – 0.02% 529
2019
Q4 		$2.04M Sell
8,200
-4,073
-33% -$954K 0.02% 545
2019
Q3 		$2.92M Buy
12,273
+1,206
+11% +$279K 0.04% 424
2019
Q2 		$2.69M Buy
11,067
+1,000
+10% +$233K 0.03% 450
2019
Q1 		$2.32M Buy
10,067
+2,642
+36% +$597K 0.03% 466
2018
Q4 		$1.55M Buy
7,425
+225
+3% +$43.9K 0.02% 506
2018
Q3 		$1.34M Hold
7,200
– – 0.02% 574
2018
Q2 		$1.52M Hold
7,200
– – 0.02% 534
2018
Q1 		$1.07M Hold
7,200
– – 0.02% 587
2017
Q4 		$895K Buy
7,200
+1,200
+20% +$168K 0.02% 607
2017
Q3 		$896K Buy
+6,000
New +$846K 0.02% 589

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Candriam SCA's MLAB Position: Q1 2023 in Review

Candriam SCA sold out of Mesa Laboratories (MLAB) in Q1 2023, closing a stake of 5,150 shares — an estimated $856K sold.

Candriam SCA first reported a position in MLAB in Q3 2017 and held it in 22 quarters. The position peaked at $2.92M in Q3 2019. 160 funds tracked by Wall St. Rank hold MLAB as of Q1 2023.

  • Candriam SCA reported no remaining Mesa Laboratories position as of Q1 2023 after selling out during the quarter.
  • Candriam SCA sold 5,150 Mesa Laboratories shares in Q1 2023, an estimated $856K.
  • Candriam SCA first reported a position in Mesa Laboratories in Q3 2017 and held it in 22 quarters.
  • Candriam SCA's Mesa Laboratories position peaked at $2.92M in Q3 2019.
  • 160 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2023.

Based on Candriam SCA's 13F filing for Q1 2023, filed 12 May 2023.